Publications by authors named "Annette Hay"

Claim this Profile
O
Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia.
Tuan Hoang, Matthew C Cheung, David N Juurlink, Kelvin K W Chan, Cindy Lau, Annette E Hay

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Safety of Third, Fourth, and Subsequent COVID-19 Vaccine Doses in Recipients of Hematopoietic Cell Transplantation and Cellular Therapy.
C Arianne Buchan, Gerard Agbayani, Katrina Hueniken, Abi Vijenthira, Michael Sebag, Annette E Hay

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental immunogenicity of multiple doses of SARS-CoV-2 vaccination in patients with haematological malignancies.
Abi Vijenthira, Sita Bhella, Katrina Hueniken, Allison M Wilkin, Michael Sebag, Annette E Hay

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Individualized Prediction Model for Early-Stage Classic Hodgkin's Lymphoma.
Angie Mae Rodday, Andrew M Evens, Matthew J Maurer, Jenica N Upshaw, Nicholas Counsell, Annette E Hay

NEJM Evid· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal Residual Disease Testing Infrastructure in Multiple Myeloma: Guidance for Clinical Trial and Routine Practice Use in Canada.
Hira S Mian, Alissa Visram, Steven Chun-Min Shih, Suzanne Trudel, Annette E Hay

Clin Lymphoma Myeloma Leuk· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of health care contact days with economic measures in the CCTG LY.12 trial.
Arjun Gupta, Tyler Thomas, Annette E Hay, Michael Crump, Marina S Djurfeldt

Oncologist· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supportive care strategies in myelodysplastic syndromes and acute myeloid leukemia in older adults: a national survey of Canadian hematologists.
Anna R Blankstein, Nora Choi, Lee Mozessohn, David Sanford, Kristjan Paulson, Annette E Hay

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and testing of a lymphoma clinical trial-specific frailty index: a secondary analysis of the NCIC-CTG LY.12 clinical trial.
Abi Vijenthira, Xinzhi Li, Michael Crump, Annette E Hay, Lois Shepherd

Leuk Lymphoma· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma.
John Kuruvilla, Christopher Rushton, Diego Villa, Muhammad Aslam, Anca Prica, Annette E Hay

Br J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies.
Sita Bhella, Allison M Wilkin, Katrina Hueniken, Abi Vijenthira, Michael Sebag, Annette E Hay

Vaccine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre-autologous stem cell transplant in relapsed/refractory diffuse large B-cell lymphoma-outcome of rituximab-dose-intensive cyclophosphamide, etoposide, cisplatin (R-DICEP) versus R-GDP.
Douglas A Stewart, John Kuruvilla, David Lee, Jill J Dudebout, Neil Chua, Annette E Hay

Br J Haematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management and use of healthcare resources in patients with chronic lymphocytic leukemia initiating venetoclax in routine clinical practice.
Versha Banerji, Andrew Aw, Nicole Laferriere, Nizar Abdel-Samad, Anthea Peters, Annette E Hay

Leuk Lymphoma· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the Associations Between Glucocorticoid Use During Hematologic Chemotherapy Treatment and New-onset Diabetes and Hyperglycemia and Mortality: A Population-based Cohort Study.
Sarah Moore-Vasram, Monakshi Sawhney, Robyn L Houlden, Patti A Groome, Catherine Goldie, Annette E Hay

Can J Diabetes· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.
Arjun Gupta, Annette E Hay, Michael Crump, Marina S Djurfeldt, Liting Zhu

Oncologist· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse Timing Is Associated With Distinct Evolutionary Dynamics in Diffuse Large B-Cell Lymphoma.
Laura K Hilton, Henry S Ngu, Brett Collinge, Kostiantyn Dreval, Susana Ben-Neriah, Annette E Hay

J Clin Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group.
Louis Everest, Bingshu E Chen, Annette E Hay, Matthew C Cheung, Kelvin K W Chan

BMC Med Res Methodol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities.
Brooke E Wilson, Annette E Hay, Kelvin Kar-Wing Chan, Matthew C Cheung, Timothy P Hanna

BMJ Open· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma.
Julie Stakiw, Shruthi Kodad, Richard LeBlanc, Michael Sebag, Annette E Hay

Clin Lymphoma Myeloma Leuk· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6.
Hira Mian, Jolie Ringash, Ralph Meyer, Annette E Hay, Lois Shepherd

Support Care Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse timing is associated with distinct evolutionary dynamics in DLBCL.
Laura K Hilton, Henry S Ngu, Brett Collinge, Kostiantyn Dreval, Susana Ben-Neriah, Annette E Hay

medRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612.
Sarit Assouline, Laura C Michaelis, Megan Othus, Annette E Hay, Roland B Walter

Leuk Lymphoma· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group.
Louis Everest, Scott Blommaert, Dongsheng Tu, Joseph L Pater, Annette Hay

Value Health· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competency-based Training Needs Assessment for Research Managers and Administrators in Africa and the United Kingdom to Strengthen Equitable Partnerships.
Victoria Nembaware, Simon Glasser, Anne Priest, Ailsa Davies, Michelle Skelton, Annette Hay

AAS Open Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation, Implementation, and Clinical Impact of the Oncomine Myeloid Targeted-Amplicon DNA and RNA Ion Semiconductor Sequencing Assay.
Christina K Ferrone, Henry Wong, Laura Semenuk, Barnaba Werunga, Brooke Snetsinger, Annette E Hay

J Mol Diagn· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group.
Kelvin K W Chan, Matthew C Cheung, Dean A Regier, Annette Hay, Alexander V Louie

Curr Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis